Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, +23

The Lancet

UrologySurgical OncologyHigh-risk Prostate CancerGenitourinary CancerOncologic Imaging +10

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial

David Ball, G Tao, Shalini Vinod, +18

The Lancet Oncology

Adaptive RadiotherapyRadiation MedicineRadiation TherapyMedicineStereotactic Ablative Radiotherapy +7

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

Andrew Kneebone, Carol Fraser‐Browne, Gillian Duchesne, +20

The Lancet Oncology

Surgical OncologyUrologyRadiation TherapyMedicineRadical Prostatectomy +8

Should extrapulmonary small cell cancer be managed like small cell lung cancer?

Sinéad Brennan, D. Gregory, Alison Stillie, +3

Cancer

Online Adaptive Radiotherapy for Muscle-Invasive Bladder Cancer: Results of a Pilot Study

Farshad Foroudi, Jacky Wong, Tomas Kron, +9

International Journal of Radiation Oncology*Biology*Physics

Adaptive RadiotherapyUrologyRadiation TherapyOnline Adaptive RadiotherapyMedicine +6

Distribution of Proliferating Bone Marrow in Adult Cancer Patients Determined Using FLT-PET Imaging

James A. Hayman, Jason Callahan, Alan Herschtal, +4

International Journal of Radiation Oncology*Biology*Physics

EngineeringOncologic ImagingPet-mriAdult Cancer PatientsPositron Emission Tomography +14

⁶⁴Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy

Rodney J. Hicks, Price Jackson, Grace Kong, +17

Journal of Nuclear Medicine

Oncologic ImagingPathologyHigh Lesion UptakePositron Emission TomographyMild Infusion-related Events +17

Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study

Danny Rischin, Madeleine King, Liz Kenny, +14

International Journal of Radiation Oncology*Biology*Physics

Weekly CisplatinRadiation MedicineOncologyCervical CancerRadiation Therapy +4

A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol

Michael S. Hofman, Declan G. Murphy, Scott Williams, +8

British Journal of Urology

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets

David T Yeung, Michael Osborn, Deborah L. White, +20

Blood